Nevertheless, we leveraged our transcriptomic analyses in eNSCs to define an oncogenic INSM1 signature that exhibited upregulation in later cycling subpopulations during evolution of a human PRO GBM tumor. The gene discussed is INSM1; the disease is neoplasm.